Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Context: The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase-catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description: We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) <0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G>C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. Conclusion: This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the first CH patients with both DUOX1 and DUOX2 mutations have been reported, suggesting that CH can have a digenic cause (225).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485 · cited 2×
“S965fsX994] are associated with CH or severely impaired H2O2-generating activity in vitro (4, 6, 7).”
BackgroundGenetic disorders coupled to ROS deficiency
O’Neill, S., Brault, J., Stasia, M.-J., & Knaus, U. G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.009 · Cited by 164
Maruo, Y., Takahashi, H., Soeda, I., Nishikura, N., Matsui, K., Ota, Y., Mimura, Y., Mori, A., Sato, H., & Takeuchi, Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0856 · Cited by 122 · cited 2×
“R434* DUOX2 mutation itself are contributing to disease severity (6, 8, 9) (Table 1).”
BackgroundNicholas, A. K., Serra, E. G., Cangul, H., Alyaarubi, S., Ullah, I., Schoenmakers, E., Deeb, A., Habeb, A. M., Almaghamsi, M., Peters, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1879 · Cited by 112 · cited 2×
“In the wider CH context, next-generation sequencing technologies are elucidating a role for oligogenicity in disease pathogenesis (10).”
BackgroundSelf-citationCaenorhabditis elegans and Human Dual Oxidase 1 (DUOX1) “Peroxidase” Domains
Meitzler, J. L., & Ortiz de Montellano, P. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013581 · Cited by 86 · cited 1×
“In vitro evaluation of a similarly truncated DUOX1 isoenzyme comprising amino acids 1 to 593 alone abolished H2O2-generating activity (5).”
BackgroundMuzza, M., Rabbiosi, S., Vigone, M. C., Zamproni, I., Cirello, V., Maffini, M. A., Maruca, K., Schoenmakers, N., Beccaria, L., Gallo, F., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3618 · Cited by 83 · cited 2×
“No DUOX1-sequencing results are reported for other cases with permanent CH associated with biallelic truncating DUOX2mutations listed in Table 1, although variants in other CH-associated genes were occasionally sought (2, 6, 9, 10).”
BackgroundSelf-citationDe Marco, G., Agretti, P., Montanelli, L., Di Cosmo, C., Bagattini, B., De Servi, M., Ferrarini, E., Dimida, A., Freitas Ferreira, A. C., Molinaro, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2467 · Cited by 70 · cited 1×
“S965fsX994] are associated with CH or severely impaired H2O2-generating activity in vitro (4, 6, 7).”
BackgroundVarela, V., Rivolta, C. M., Esperante, S. A., Gruñeiro-Papendieck, L., Chiesa, A., & Targovnik, H. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.058321 · Cited by 66 · cited 3×
“S965fsX994] are associated with CH or severely impaired H2O2-generating activity in vitro (4, 6, 7).”
BackgroundFu, C., Luo, S., Zhang, S., Wang, J., Zheng, H., Yang, Q., Xie, B., Hu, X., Fan, X., Luo, J., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.04.019 · Cited by 58 · cited 6×
“R434* DUOX2 mutation itself are contributing to disease severity (6, 8, 9) (Table 1).”
BackgroundInfluentialMutation screening of DUOX2 in Chinese patients with congenital hypothyroidism
Fu, C., Zhang, S., Su, J., Luo, S., Zheng, H., Wang, J., Qin, H., Chen, Y., Shen, Y., Hu, X., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0382-8 · Cited by 37
Tan, M., Huang, Y., Jiang, X., Li, P., Tang, C., Jia, X., Chen, Q., Chen, W., Sheng, H., Feng, Y., et al. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-112224 · Cited by 37
A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
Cangül, H., Aycan, Z., Kendall, M., Baş, V. N., Sağlam, Y., Barrett, T. G., & Maher, E. R. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0314 · Cited by 18 · cited 2×
“R434*), both of whom exhibited uncharacteristically severe CH (3).”
BackgroundSelf-citation
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Moreover, the first CH patients with both DUOX1 and DUOX2 mutations have been reported, suggesting that CH can have a digenic cause (225).”
BackgroundSelf-citationDIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
Peters, C., van Trotsenburg, A. S. P., & Schoenmakers, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0383 · Cited by 162
Self-citationBuvelot, H., Jaquet, V., & Krause, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_2 · Cited by 146
Sun, F., Zhang, J., Yang, C., Gao, G.-Q., Zhu, W., Han, B., Zhang, L., Wan, Y., Ye, X., Ma, Y., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1017 · Cited by 110
Congenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“More recently, the first evidence of a physiologic role for DUOX1 in humans was provided by a report of two siblings with homozygous inactivating mutations in both DUOX1 and DUOX2 associated with congenital hypothyroidism more severe than is typically observed in DUOX2 deficiency alone [17].”
Background
Metadata
- Authors
- Aycan, Z., Cangul, H., Muzza, M., Bas, V. N., Fugazzola, L., Chatterjee, V. K., Persani, L., & Schoenmakers, N.
- Affiliations
- Dr Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi (TR)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Milan (IT)
- University of Cambridge (GB)
- Corresponding author
- Schoenmakers, Nadia
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-06-16
- Volume
- 102
- Issue
- 9
- Pages
- 3085-3090
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5587079
- OpenAlex
- W2626775677
- Cited by
- 60
- References
- 12
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 1
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (100585, 095564/Z/11/Z, /Z/11/Z, 095564, 100585/Z/12/Z)
- National Institute for Health and Care Research (NF-SI-0514-10176)
- Ministero della Salute (RF-2010-2309484, RF 2010, 2010-2309484)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (214S637)
- Medical Research Council (MC_PC_12012)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- congenital hypothyroidism, DUOX1, DUOX2, thyroid peroxidase, hydrogen peroxide, thyroid hormone synthesis, aberrant splicing, loss-of-function mutations, phenotypic variability
- MeSH terms
- Dual Oxidases, Congenital Hypothyroidism, Female, Genotype, Humans, Infant, Infant, Newborn, Male, Pedigree, Phenotype, Retrospective Studies, Severity of Illness Index, Thyroid Function Tests, Genetic Variation, Cohort Studies, Codon, Nonsense, NADPH Oxidases, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.